Panacea Venture is a life sciences venture capital firm founded in 2017 with offices in Shanghai, Hong Kong, and Silicon Valley. The firm focuses on investing in and incubating early-stage life science companies with breakthrough technologies that address unmet medical needs.
52% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $45.8M (across 20 rounds with reported amounts).
Portfolio
18
Fund Size
—
Top Stage
Series A
Last 12 Mo
2
Team
James Huang
Founder and Managing Partner
Andrew Aherrera
Partner
Andrew Ng
Partner
Arthur Chen
Partner
Benjamin Chen
Scientific Partner
Carl Firth
Partner
Fay Xing
Scientific Partner
Jeffry Wu
Partner
Mathias Hukkelhoven, PhD
Venture Partner
Michelle Chung
Venture Partner
Nancy Donahue
Venture Partner
Nikki Zhang
Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| SSeismic Pharma | Unknown | — | Mar 2026 |
 Kainova Therapeutics | Series B | — | Feb 2026 |
 VelaVigo | Seed | $60M | Jul 2025 |
 Outsee | Seed | — | Jun 2025 |
 Human Longevity | Series B | $39.8M | Aug 2024 |
 Human Longevity Inc (HLI) | Series B | $39.8M | Aug 2024 |
 Actym Therapeutics | Series A | $59.5M | Oct 2023 |
 hC Bioscience | Series A | $16M | Nov 2022 |
 Domain Therapeutics | Series A | $42M | May 2022 |
| Domain Therapeutics | Series A | $42M | Jan 2022 |
| Kainova Therapeutics | Series A | $42M | Jan 2022 |
 Triarm Therapeutics | Unknown | $60M | Sep 2021 |
| IInmagene | Series C | $100M | Jun 2021 |
| IInmagene | Series B | $21M | Nov 2020 |
 XW Pharma | Series C | $40M | Sep 2020 |
| Actym Therapeutics | Series A | $34M | Apr 2020 |
 Tailai Biosciences | Seed | $10M | Jan 2020 |
 XWPharma | Series C | $40M | Jan 2020 |
| XXW Laboratories | Series C | $58M | Jan 2020 |
| OOncologie | Series B | $80M | Jun 2019 |
| OOncologie | Series B | $80M | Jan 2019 |
 Tactiva Therapeutics | Series A | $35M | Dec 2018 |
| GGT Apeiron Therapeutics | Series A | $17.5M | — |
Top Co-Investors
Last updated: 7 October 2026